Your browser doesn't support javascript.
loading
Measuring Binding at the Putative Melatonin Receptor MT3.
Legros, Céline; Dupuis, Philippe; Ferry, Gilles; Boutin, Jean A.
Afiliação
  • Legros C; Eurofins, Discovery, Eurofins Cerep, Celle-Levescault, France.
  • Dupuis P; Eurofins, Discovery, Eurofins Cerep, Celle-Levescault, France.
  • Ferry G; Pole d'expertise Biotechnologie, Chimie & Biologie, Institut de Recherches Servier, Croissy-sur-Seine, France.
  • Boutin JA; Pole d'expertise Biotechnologie, Chimie & Biologie, Institut de Recherches Servier, Croissy-sur-Seine, France. ja.boutin.pro@gmail.com.
Methods Mol Biol ; 2550: 283-289, 2022.
Article em En | MEDLINE | ID: mdl-36180699
ABSTRACT
Melatonin, (N-acetyl-5-methoxytryptamine), is a neurohormone which possesses a wide range of biological effects. The effects mediated by melatonin are in part attributed to the antioxidant properties of the molecule. For a long time, melatonin had been described as a ligand of a putative "receptor" present in mammalian brains named MT3. Several studies were thus carried out with the goal of clarifying the nature of this melatonin "receptor." The experimental setup of the binding measurements is unusual. The present chapter aims at describing this technique. This binding site was confirmed independently by several groups, and it was eventually demonstrated that MT3 was the enzyme quinone reductase 2 (NQO2).
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Quinona Redutases / Melatonina Limite: Animals Idioma: En Revista: Methods Mol Biol Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Quinona Redutases / Melatonina Limite: Animals Idioma: En Revista: Methods Mol Biol Ano de publicação: 2022 Tipo de documento: Article